Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1975 1
1979 2
1980 2
1982 1
1983 1
1984 1
1985 2
1986 3
1987 1
1988 1
1989 5
1990 2
1991 5
1992 6
1993 6
1994 2
1995 5
1996 2
1997 9
1998 3
1999 2
2000 8
2001 6
2002 11
2003 11
2004 11
2005 13
2006 8
2007 9
2008 9
2009 14
2010 33
2011 41
2012 45
2013 54
2014 56
2015 67
2016 80
2017 67
2018 62
2019 79
2020 69
2021 55
2022 37
2023 10
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 25832686

763 results

Results by year

Filters applied: . Clear all
Page 1
Phase II study evaluating the addition of cetuximab to the concurrent delivery of weekly carboplatin, paclitaxel, and daily radiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck.
Suntharalingam M, Kwok Y, Goloubeva O, Parekh A, Taylor R, Wolf J, Zimrin A, Strome S, Ord R, Cullen KJ. Suntharalingam M, et al. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1845-50. doi: 10.1016/j.ijrobp.2011.02.062. Epub 2011 May 19. Int J Radiat Oncol Biol Phys. 2012. PMID: 21601372 Free PMC article. Clinical Trial.
Phase II study of docetaxel, cisplatin, and concurrent radiation followed by platinum-based adjuvant chemotherapy for technically unresectable, locally advanced head and neck squamous cell carcinoma.
Nakahara S, Takenaka Y, Ogawa K, Nishiike S, Yamamoto Y, Seo Y, Isohashi F, Suzuki O, Yoshioka Y, Sumida I, Yoshii T, Tomiyama Y, Inohara H. Nakahara S, et al. Int J Clin Oncol. 2016 Dec;21(6):1030-1037. doi: 10.1007/s10147-016-0997-6. Epub 2016 Jun 15. Int J Clin Oncol. 2016. PMID: 27306220 Clinical Trial.
Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
Spreafico A, Huang SH, Xu W, Granata R, Liu CS, Waldron JN, Chen E, Ringash J, Bayley A, Chan KK, Hope AJ, Cho J, Razak AA, Hansen A, Jang R, Perez-Ordonez B, Weinreb I, Bossi P, Orlandi E, Licitra LF, Song Y, O'Sullivan B, Siu LL, Kim J. Spreafico A, et al. Eur J Cancer. 2016 Nov;67:174-182. doi: 10.1016/j.ejca.2016.08.013. Epub 2016 Sep 24. Eur J Cancer. 2016. PMID: 27669504
A phase I trial of weekly docetaxel and cisplatinum combined to concurrent hyperfractionated radiotherapy for non-small cell lung cancer and squamous cell carcinoma of head and neck.
Varveris H, Mazonakis M, Vlachaki M, Kachris S, Lyraraki E, Zoras O, Maris T, Froudarakis M, Velegrakis J, Perysinakis C, Damilakis J, Samonis G. Varveris H, et al. Oncol Rep. 2003 Jan-Feb;10(1):185-95. doi: 10.3892/or.10.1.185. Oncol Rep. 2003. PMID: 12469168 Clinical Trial.
763 results